Cargando…
Targeting HCV Entry For Development of Therapeutics
Recent progress in defining the molecular mechanisms of Hepatitis C Virus (HCV) entry affords the opportunity to exploit new viral and host targets for therapeutic intervention. Entry inhibitors would limit the expansion of the infected cell reservoir, and would complement the many replication inhib...
Autores principales: | Wong-Staal, Flossie, Syder, Andrew J., McKelvy, Jeffrey F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185726/ https://www.ncbi.nlm.nih.gov/pubmed/21994703 http://dx.doi.org/10.3390/v2081718 |
Ejemplares similares
-
Is feedback to medical learners associated with characteristics of improved patient care?
por: Hayes, Victoria, et al.
Publicado: (2017) -
Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry Target
por: Gededzha, Maemu Petronella, et al.
Publicado: (2014) -
A Species-Level Phylogeny of Extant Snakes with Description of a New Colubrid Subfamily and Genus
por: Figueroa, Alex, et al.
Publicado: (2016) -
HCV entry receptors as potential targets for siRNA-based inhibition of HCV
por: Jahan, Shah, et al.
Publicado: (2011) -
Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)